An in vitro study on the compatibility and precipitation of a combination of ciprofloxacin and vancomycin in human vitreous

British Journal of Ophthalmology

Volumn 88, Issue 2, 2004, Pages 218-222

  Hui, M ^a   Kwok, A K H ^a,b   Pang, C P ^a   Cheung, S W ^a   Chan, R C Y ^a   Lam, D S C ^a   Cheng, A F B ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BALANCED SALT SOLUTION; CIPROFLOXACIN; SODIUM CHLORIDE; VANCOMYCIN;

AGED; ARTICLE; BODY TEMPERATURE; DRUG EFFECT; EQUILIBRIUM DIALYSIS; FLUORESCENCE POLARIZATION IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INCUBATION TIME; PRECIPITATION; PRIORITY JOURNAL; VITREOUS BODY;

AGED; BODY TEMPERATURE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; DIALYSIS; DRUG INTERACTIONS; DRUG STABILITY; DRUG THERAPY, COMBINATION; GRAM-NEGATIVE BACTERIA; HUMANS; HYDROGEN-ION CONCENTRATION; PRECIPITATION; SODIUM CHLORIDE; VANCOMYCIN; VITREOUS BODY;

EID: 0942290465     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2003.017947     Document Type: Article

References (24)

1. Callegan MC, Engelbert M, Parke DW 2nd, et al. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions, Clin Microbiol Rev 2002;15:111-24.
2. Roth DB, Flynn HW Jr. Antibiotic selection in the treatment of endophthalmitis: the significance of drug combinations and synergy. Surv Ophthalmol 1997;41:395-401.
3. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479-96.
4. Campochiaro PA, Lim JI. Aminoglycoside toxicity in the treatment of endophthalmitis. The Aminoglycoside Toxicity Study Group. Arch Ophthalmol 1994;112:48-53.
5. Aaberg TM, Flynn HW, Murray TG. Intraocular ceftazidime as an alternative to the aminoglycosides in the treatment of endophthalmitis. Arch Ophthalmol 1994;112:18-19.
6. Lim JI, Campochiaro PA. Successful treatment of gram-negative endophthalmitis with intravifreous ceftazidime. Arch Ophthalmol 1992;110:1686.
7. Campochiaro PA, Green WR. Toxicity of intravitreous ceftazidime in primate retina. Arch Ophthalmol 1992;110:1625-9.
8. Lifshitz T, Lapid-Gortzak R, Finkelman Y, et al. Vancomycin and ceftazidime incompatibility upon intravitreal injection. Br J Ophthalmol 2000;84:117-118.
9. Kwok AKH, Hui M, Pang CP, et al. An in vitro Study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis. Invest Ophthalmol Vis Sci 2002;43:1182-8.
10. Hooper DC, Wolfson JS. Mode of action of the quinolone antimicrobial agents: review of recent information. Rev Infect Dis 1989;11:S902-11.
11. Eliopoulos GM, Gardella A, Moellering RC Jr. In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent. Antimicrob Agents Chemother 1984;25:331-5.
12. Walker RC. The fluoroquinolones. Mayo Clin Proc 1999;74:1030-7.
13. Wiechens B, Grammer JB, Johannsen U, et al. Experimental intravitreal application of ciprofloxacin in rabbits. Ophthalmologica 1999;213:120-8.
14. Hainsworth DP, Conklin JD, Bierly JR, et al. Intravitreal delivery of ciprofloxacin. J Ocul Pharmacol Ther 1996;12:183-91.
15. Jim LK. Physical and chemical compatibility of intravenous ciprofloxacin with other drugs. Ann Pharmacother 1993;27:704-7.
16. Chan CY, Lam A, French GL. Rapid HPLC assay of fluoroquinolones in clinical specimens. J Antimicrob Chemother 1989;23:597-604.
17. Han DP, Wisniewski SR, Wilson LA. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996;122:1-17.
18. Irvine WD, Flynn HW, Miller D, et al. Endophthalmitis caused by gram-negative organisms. Arch Ophthalmol 1992;110:1450-4.
19. Ling TK, Liu EY, Cheng AF. A 13-year study of antimicrobial susceptibility of common gram-negative bacteria isolated from the bloodstream in a teaching hospital. Chemotherapy 2001;47:29-38.
20. Benz MS, Scott IU, Flynn HW, et al. In vitro susceptibilities to antimicrobials of pathogens isolated from the vitreous cavity of patients with endophthalmitis. Invest Ophthalmol Vis Sci 2002;43:E-Abstract 4428.
21. Kunimoto DY, Das T, Sharma S, et al. Microbiologic spectrum and susuceptibility of isolates: Part I. Postoperative endophthalmitis. Am J Ophthalmol 1999;128:240-2.
22. Kunimoto DY, Das T, Sharma S, et al. Microbiologic soectrum and susuceptibility of isolates: Part II. Posttraumatic endophthalmitis. Am J Ophthalmol 1999;128:242-4.
23. Moorhead LC, Redburn DA, Merritt J, et al. The effects of intravitreal irrigation during vitrectomy on the electroretinogram. Am J Ophthalmol 1979;88:239-45.
24. Edelhauser HF, Van Horn DL, Aaberg TM. Intraocular irrigating solutions and their use for vitrectomy. Monograph 1976;2:265-87.